Ma Man-Yao, Xu Wen
School of Pharmacy, Shandong University of Chinese Medicine, Jinan, Shandong 250355, China.
Zhonghua Nan Ke Xue. 2024 Feb;30(2):104-110.
To explore the effect of tanshinone on the invasion of PCa cells induced by androgen-deprivation therapy (ADT) and its possible action mechanism.
We treated human PCa LNCaP cells with tanshinone at 0 nmol/L (the control group), 5 nmol/L (tanshinone group 1), 10 nmol/L (tanshinone group 2) and 20 nmol/L (tanshinone group 3), respectively. Then we detected their cloning, angiogenesis and invasion abilities by plate cloning assay, tube-formation assay and Transwell chamber assay, respectively, examined their apoptosis using the AnnexinV-FITC/PI double staining method, and determined the protein expressions of phosphatidylinositol 3-kinase (PI3K), p-PI3K, protein kinase B (AKT) and p-AKT by Western blot.
Compared with the control group, the PCa LNCaP cells in the tanshinone groups 1, 2 and 3 showed significant dose-dependent decreases in the clone formation rate ([25.14 ± 5.19]% vs [19.33 ± 4.12]% vs [14.69 ± 4.71]% vs [9.35 ± 2.37]%, P<0.05), number of cellular lumens ([23.20 ± 4.85] vs [19.80 ± 5.12] vs [14.40 ± 4.16] vs [10.20 ± 3.21] per microscopic field, P<0.05) and count of transmembrane cells ([62.80 ± 8.97] vs [50.40 ± 7.62] vs [38.60 ± 5.16] vs [27.40 ± 4.91] per microscopic field, P<0.05), increase in the rate of cell apoptosis ([3.58 ± 0.74]% vs [8.97 ± 1.36]% vs [14.64 ± 4.10]% vs [21.17 ± 5.37]%, P<0.05), and down-regulation of the expressions of p-PI3K, PI3K, p-AKT and AKT (P<0.05).
Tanshinone can reverse ADT-induced invasion of PCa cells, reduce their clone formation and angiogenesis, promote their apoptosis, and inhibit the activity of PI3K and AKT signaling pathways.
探讨丹参酮对去势雄激素治疗(ADT)诱导的前列腺癌细胞侵袭的影响及其可能的作用机制。
分别用0 nmol/L(对照组)、5 nmol/L(丹参酮组1)、10 nmol/L(丹参酮组2)和20 nmol/L(丹参酮组3)的丹参酮处理人前列腺癌LNCaP细胞。然后分别通过平板克隆实验、管腔形成实验和Transwell小室实验检测其克隆、血管生成和侵袭能力,采用AnnexinV-FITC/PI双染法检测其凋亡情况,并通过蛋白质印迹法测定磷脂酰肌醇3激酶(PI3K)、磷酸化PI3K(p-PI3K)、蛋白激酶B(AKT)和磷酸化AKT(p-AKT)的蛋白表达。
与对照组相比,丹参酮组1、2和3中的前列腺癌LNCaP细胞克隆形成率显著呈剂量依赖性降低([25.14±5.19]%对[19.33±4.12]%对[14.69±4.71]%对[9.35±2.37]%,P<0.05),每个显微镜视野下的细胞管腔数显著降低([23.20±4.85]对[19.80±5.12]对[14.40±4.16]对[10.20±3.21],P<0.05),每个显微镜视野下的跨膜细胞数显著降低([62.80±8.97]对[50.40±7.62]对[38.60±5.16]对[27.40±4.91],P<0.05),细胞凋亡率显著升高([3.58±0.74]%对[8.97±1.36]%对[14.64±4.10]%对[21.17±5.37]%,P<0.05),且p-PI3K、PI3K、p-AKT和AKT的表达下调(P<0.05)。
丹参酮可逆转ADT诱导的前列腺癌细胞侵袭,降低其克隆形成和血管生成,促进其凋亡,并抑制PI3K和AKT信号通路的活性。